Stocks
Funds
Screener
Sectors
Watchlists

Latest FARALLON CAPITAL MANAGEMENT LLC Stock Portfolio

FARALLON CAPITAL MANAGEMENT LLC Performance:
2025 Q1: -4.51%YTD: -4.51%2024: 20.01%

Performance for 2025 Q1 is -4.51%, and YTD is -4.51%, and 2024 is 20.01%.

About FARALLON CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings

FARALLON CAPITAL MANAGEMENT LLC is a hedge fund based in SAN FRANCISCO, CA. On 20-Jul-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $41.2 Billions. In it's latest 13F Holdings report, FARALLON CAPITAL MANAGEMENT LLC reported an equity portfolio of $17.9 Billions as of 31 Mar, 2025.

The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are MSFT, EXEL, UNH. The fund has invested 4.8% of it's portfolio in MICROSOFT CORP and 4.6% of portfolio in EXELIXIS INC.

The fund managers got completely rid off AIRBNB INC (ABNB), HASHICORP INC (HCP) and BRISTOL-MYERS SQUIBB CO (BMY) stocks. They significantly reduced their stock positions in HEALTHCARE RLTY TR (HR), ARROWHEAD PHARMACEUTICALS IN (ARWR) and DYNE THERAPEUTICS INC (DYN). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in INTRA-CELLULAR THERAPIES INC (ITCI), SOMNIGROUP INTERNATIONAL INC (TPX) and VERONA PHARMA PLC (VRNA). The fund showed a lot of confidence in some stocks as they added substantially to HEALTHEQUITY INC (HQY), GLOBUS MED INC (GMED) and GE HEALTHCARE TECHNOLOGIES I.

FARALLON CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500

Our best estimate is that FARALLON CAPITAL MANAGEMENT LLC made a return of -4.51% in the last quarter. In trailing 12 months, it's portfolio return was 5.92%.

New Buys

Ticker$ Bought
intra-cellular therapies inc403,016,000
somnigroup international inc79,415,400
verona pharma plc68,886,000
alkermes plc45,891,200
abbott labs44,172,400
beta bionics inc40,786,400
cardinal health inc37,611,200
joyy inc32,744,400

New stocks bought by FARALLON CAPITAL MANAGEMENT LLC

Additions

Ticker% Inc.
healthequity inc14,964
globus med inc2,205
ge healthcare technologies i333
vnet group inc275
flutter entmt plc167
forte biosciences inc101
salesforce inc62.55
genedx holdings corp55.38

Additions to existing portfolio by FARALLON CAPITAL MANAGEMENT LLC

Reductions

Ticker% Reduced
healthcare rlty tr-99.63
arrowhead pharmaceuticals in-97.49
dyne therapeutics inc-95.64
soleno therapeutics inc-94.44
silicon motion technology co-92.94
zymeworks inc-69.92
full truck alliance co ltd-55.64
biodesix inc-51.22

FARALLON CAPITAL MANAGEMENT LLC reduced stake in above stock

Sold off

Ticker$ Sold
zto express cayman inc-54,598,100
hashicorp inc-220,757,000
matterport inc-24,027,500
elevation oncology inc-1,984,560
bristol-myers squibb co-180,313,000
airbnb inc-319,221,000
endeavor group hldgs inc-57,422,900
gds hldgs ltd-36,379,700

FARALLON CAPITAL MANAGEMENT LLC got rid off the above stocks

Sector Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 46.7% of it's holdings in Healthcare sector.

Sector%
Healthcare46.7
Technology17.2
Industrials10
Financial Services8.3
Communication Services8
Others5.5
Real Estate2.1
Consumer Defensive1.5

Market Cap. Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 60% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP39.4
MID-CAP32.9
MEGA-CAP20.6
UNALLOCATED5.5
SMALL-CAP1.3

Stocks belong to which Index?

About 71% of the stocks held by FARALLON CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
S&P 50052.1
Others29
RUSSELL 200018.9
Top 5 Winners (%)%
BGNE
beigene ltd
47.4 %
SAGE
sage therapeutics inc
46.4 %
AXSM
axsome therapeutics inc
37.8 %
PGNY
progyny inc
29.5 %
PTGX
protagonist therapeutics inc
25.3 %
Top 5 Winners ($)$
EXEL
exelixis inc
84.6 M
PTGX
protagonist therapeutics inc
59.6 M
MCK
mckesson corp
58.6 M
BSX
boston scientific corp
58.1 M
HIMS
hims & hers health inc
47.2 M
Top 5 Losers (%)%
RVMD
revolution medicines inc
-76.5 %
IRWD
ironwood pharmaceuticals inc
-66.8 %
CGC
canopy growth corp
-66.8 %
SLDP
solid power inc
-62.2 %
CCCC
c4 therapeutics inc
-55.6 %
Top 5 Losers ($)$
SRPT
sarepta therapeutics inc
-143.0 M
RVMD
revolution medicines inc
-112.5 M
CRM
salesforce inc
-111.2 M
MSFT
microsoft corp
-96.8 M
AON
aon plc
-96.4 M

FARALLON CAPITAL MANAGEMENT LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC

FARALLON CAPITAL MANAGEMENT LLC has 132 stocks in it's portfolio. About 36% of the portfolio is in top 10 stocks. SRPT proved to be the most loss making stock for the portfolio. EXEL was the most profitable stock for FARALLON CAPITAL MANAGEMENT LLC last quarter.

Last Reported on: 15 May, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions